Molecular imaging using 18F-FDG PET/CT and circulating inflammatory and immune indicators to predict pathological response to neoadjuvant camrelizumab plus chemotherapy in resectable stage IIIA–IIIB NSCLC

Related articles

1. Feasibility analysis of metabolic parameters based on baseline 18 F-FDG PET/CT to predict heterogeneity and recurrence of diffuse large B-cell lymphoma

   This article has 6 authors:

   1. Fan Ge
   2. Tingting Wu
   3. Xinyue Yang
   4. Mengye Peng
   5. Chen Yang
   6. Kezheng Wang

2. Prognostic value of pretreatment metabolic tumor volume on [S-methyl-11C]-L-methionine PET/CT in patients with local non-small cell lung carcinoma treated with single-fraction carbon-ion radiotherapy

   This article has 11 authors:

   1. Kentaro Tamura
   2. Ryuichi Nishii
   3. Atsushi B Tsuji
   4. Jitsuro Tsukada
   5. Takamasa Maeda
   6. Mio Nakajima
   7. Shigeru Yamada
   8. Hitoshi Ishikawa
   9. Kana Yamazaki
   10. Tatsuya Higashi
   11. Masahiro Jinzaki

3. Morphological Analysis of Tumor Microenvironment in HER2-Positive Breast Cancer: Predicting Response to Neoadjuvant Chemotherapy on Histopathological Images

   This article has 3 authors:

   1. Wensheng Cui
   2. Ming Fan
   3. Lihua Li